Excalibur Management Corp Q4 2022 vs. Q1 2023 13F Holdings Comparison

Excalibur Management Corp recently filed their 13F form, revealing their holdings for the fourth quarter of 2022 and the first quarter of 2023. The filing provides a glimpse into the changes that the company made in their investment portfolio during this period.

One of the notable changes in Excalibur's holdings was in Apple Inc (AAPL), where they reduced their shares from 60,229 to 59,663, but increased their value from $7,825,000 to $9,838,000, representing a 25.7% jump in value. Meanwhile, their holdings in Pfizer Inc (PFE) decreased significantly, with shares dropping from 153,628 to 153,602 and value falling from $7,871,000 to $6,266,000, resulting in a 20.4% decrease.

Another interesting change was in Meta Platforms Inc (META), where Excalibur increased their shares from 9,922 to 9,973, but the value surged from $1,194,000 to $2,113,000, representing a whopping 77% increase. This may reflect the growing popularity of Meta Platforms' flagship product, Facebook.

Excalibur's position in Amazon.com Inc (AMZN) also saw a jump in value from $1,019,000 to $1,306,000, representing a 28.2% increase. However, the company decided to divest a substantial amount of their investment in CVS Health Corp (CVS), with their shares dropping from 44,135 to 43,650 and value decreasing from $4,112,000 to $3,243,000, representing a 21.1% decline.

Among the other holdings that saw significant value changes were FedEx Corp (FDX), with value increasing from $1,555,000 to $2,029,000 (a 30.5% increase), and Intel Corp (INTC), with value surging from $1,557,000 to $1,933,000 (a 24.1% increase).

Excalibur Management's overall holdings decreased slightly from $122,710,000 in Q4 2022 to $119,881,000 in Q1 2023, a drop of about 2.3%. This decline could be due to various factors such as market fluctuations and company-specific events.

In conclusion, examining Excalibur Management's 13F filings reveals that the company made some significant changes in their investment portfolio during the fourth quarter of 2022 and first quarter of 2023. While some stocks experienced significant value surges, others saw a substantial decrease in value. It remains to be seen how these investments will perform and whether Excalibur will continue to hold them in the future.